Tepezza 500 mg

Tepezza 500 mg is a medicine authorised by Swissmedic under authorisation number 69795. The authorisation holder is Amgen Switzerland AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 30 April 2025 and the authorisation is limited until 29 April 2030. ATC code L04AG13 places the medicine in the group Immunosuppressants.

  • Dispensing category A
  • Authorisation number 69795
  • ATC L04AG13
  • Biotechnological medicines
Authorisation data
Authorisation number69795
NameTepezza 500 mg
Full nameTepezza 500 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderAmgen Switzerland AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL04AG13
First authorisation30 April 2025
Authorisation validity29 April 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Tepezza 500 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA30 April 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L04AG1307.15.0.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Tepezza 500 mg authorised in Switzerland?

Yes. Tepezza 500 mg is authorised by Swissmedic under authorisation number 69795, data as of 01 September 2026. The authorisation is limited until 29 April 2030.

Which dispensing category does Tepezza 500 mg have?

Tepezza 500 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Tepezza 500 mg?

The authorisation holder is Amgen Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com